COVID-19 Infection-Related Weight Loss Decreases Eating/Swallowing Function in Schizophrenic Patients

Overview

Journal Nutrients

Date 2021 Apr 3

PMID 33805263

Citations 1

Authors

Takeshi Kikutani

Yoko Ichikawa

Eri Kitazume

Arato Mizukoshi

Takashi Tohara

Noriaki Takahashi

Fumiyo Tamura

Manami Matsutani

Junko Onishi

Eiichiro Makino

Affiliations

Soon will be listed here.

Abstract

Background: In older people with psychoneurological diseases, COVID-19 infection may be associated with a risk of developing or exacerbating dysphagia. The aim of the present study was to examine the relationship between eating/swallowing function and COVID-19 infection.

Methods: Subjects were 44 inpatients with confirmed COVID-19 infection being treated for schizophrenia in a psychiatric ward. Eating function was assessed using the Food Intake Level Scale (FILS) before and after infection. We also evaluated age, comorbidities, COVID-19 hospital stay, obesity index, weight loss rate, and chlorpromazine equivalent.

Results: Subjects had a mean age of 68.86 years. Pre-infection, 20 subjects had a FILS score of 7-9 (presence of eating/swallowing disorder) and 24 subjects had a score of 10 (normal). Eating function after infection resolution showed decreasing FILS score compared to that before infection in 14 subjects (74.14 years). Six subjects (79.3 years) transitioned from oral feeding to parenteral feeding. A ≥ 10% weight loss during infection treatment was significantly associated with decreased eating function and a transition to parenteral feeding. Chlorpromazine equivalents, comorbidities, and number of days of hospitalization showed no associations with decreased eating function.

Conclusions: Preventing malnutrition during treatment for COVID-19 infection is important for improving post-infection life prognosis and maintaining quality of life (QOL).

Citing Articles

Cytokines and Chemokines in Cancer Cachexia and Its Long-Term Impact on COVID-19.

Singh S, Singh R Cells. 2022; 11(3).

PMID: 35159388 PMC: 8834385. DOI: 10.3390/cells11030579.

References

Yao H, Chen J, Xu Y . Patients with mental health disorders in the COVID-19 epidemic. Lancet Psychiatry. 2020; 7(4):e21. PMC: 7269717. DOI: 10.1016/S2215-0366(20)30090-0. View

Kunieda K, Ohno T, Fujishima I, Hojo K, Morita T . Reliability and validity of a tool to measure the severity of dysphagia: the Food Intake LEVEL Scale. J Pain Symptom Manage. 2012; 46(2):201-6. DOI: 10.1016/j.jpainsymman.2012.07.020. View

Fujishima I, Fujiu-Kurachi M, Arai H, Hyodo M, Kagaya H, Maeda K . Sarcopenia and dysphagia: Position paper by four professional organizations. Geriatr Gerontol Int. 2019; 19(2):91-97. DOI: 10.1111/ggi.13591. View

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

Allard L, Ouedraogo E, Molleville J, Bihan H, Giroux-Leprieur B, Sutton A . Malnutrition: Percentage and Association with Prognosis in Patients Hospitalized for Coronavirus Disease 2019. Nutrients. 2020; 12(12). PMC: 7761464. DOI: 10.3390/nu12123679. View

Xie Q, Fan F, Fan X, Wang X, Chen M, Zhong B . COVID-19 patients managed in psychiatric inpatient settings due to first-episode mental disorders in Wuhan, China: clinical characteristics, treatments, outcomes, and our experiences. Transl Psychiatry. 2020; 10(1):337. PMC: 7531059. DOI: 10.1038/s41398-020-01022-x. View

Charlson M, Pompei P, Ales K, MacKenzie C . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373-83. DOI: 10.1016/0021-9681(87)90171-8. View

Evans W, Morley J, Argiles J, Bales C, Baracos V, Guttridge D . Cachexia: a new definition. Clin Nutr. 2008; 27(6):793-9. DOI: 10.1016/j.clnu.2008.06.013. View

Maguire P, Reay R, Looi J . Nothing to sneeze at - uptake of protective measures against an influenza pandemic by people with schizophrenia: willingness and perceived barriers. Australas Psychiatry. 2018; 27(2):171-178. PMC: 7227129. DOI: 10.1177/1039856218815748. View

10.

Morley J, Kalantar-Zadeh K, Anker S . COVID-19: a major cause of cachexia and sarcopenia?. J Cachexia Sarcopenia Muscle. 2020; 11(4):863-865. PMC: 7300782. DOI: 10.1002/jcsm.12589. View

11.

Whittle J, Molinger J, Macleod D, Haines K, Wischmeyer P . Persistent hypermetabolism and longitudinal energy expenditure in critically ill patients with COVID-19. Crit Care. 2020; 24(1):581. PMC: 7521195. DOI: 10.1186/s13054-020-03286-7. View

12.

Lee S, Yang J, Moon S, Yoo I, Ha E, Kim S . Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study. Lancet Psychiatry. 2020; 7(12):1025-1031. PMC: 7498216. DOI: 10.1016/S2215-0366(20)30421-1. View

13.

Kulkarni D, Kamath V, Stewart J . Swallowing Disorders in Schizophrenia. Dysphagia. 2017; 32(4):467-471. DOI: 10.1007/s00455-017-9802-6. View

14.

Lehman A, Steinwachs D . Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophr Bull. 1998; 24(1):1-10. DOI: 10.1093/oxfordjournals.schbul.a033302. View

15.

Frajkova Z, Tedla M, Tedlova E, Suchankova M, Geneid A . Postintubation Dysphagia During COVID-19 Outbreak-Contemporary Review. Dysphagia. 2020; 35(4):549-557. PMC: 7255443. DOI: 10.1007/s00455-020-10139-6. View

16.

Cederholm T, Jensen G, Correia M, Gonzalez M, Fukushima R, Higashiguchi T . GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community. J Cachexia Sarcopenia Muscle. 2019; 10(1):207-217. PMC: 6438340. DOI: 10.1002/jcsm.12383. View

17.

Aoyagi Y, Ohashi M, Funahashi R, Otaka Y, Saitoh E . Oropharyngeal Dysphagia and Aspiration Pneumonia Following Coronavirus Disease 2019: A Case Report. Dysphagia. 2020; 35(4):545-548. PMC: 7290133. DOI: 10.1007/s00455-020-10140-z. View

18.

Virgens I, Santana N, Lima S, Fayh A . Can COVID-19 be a risk for cachexia for patients during intensive care? Narrative review and nutritional recommendations. Br J Nutr. 2020; 126(4):552-560. PMC: 7711335. DOI: 10.1017/S0007114520004420. View

19.

Lechien J, Chiesa-Estomba C, De Siati D, Horoi M, Le Bon S, Rodriguez A . Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020; 277(8):2251-2261. PMC: 7134551. DOI: 10.1007/s00405-020-05965-1. View

20.

Haga T, Ito K, Sakashita K, Iguchi M, Ono M, Tatsumi K . Risk factors for pneumonia in patients with schizophrenia. Neuropsychopharmacol Rep. 2018; 38(4):204-209. PMC: 7292272. DOI: 10.1002/npr2.12034. View